These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20797593)

  • 21. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE).
    Kindermann M; Hennen B; Jung J; Geisel J; Böhm M; Fröhlig G
    J Am Coll Cardiol; 2006 May; 47(10):1927-37. PubMed ID: 16697307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
    Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
    Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Sutton MG; Plappert T; Hilpisch KE; Abraham WT; Hayes DL; Chinchoy E
    Circulation; 2006 Jan; 113(2):266-72. PubMed ID: 16401777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristics.
    Thibault B; Harel F; Ducharme A; White M; Frasure-Smith N; Roy D; Philippon F; Dorian P; Talajic M; Dubuc M; Gagné P; Guerra PG; Macle L; Rivard L; Khairy P
    Can J Cardiol; 2011; 27(6):779-86. PubMed ID: 21791363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute hemodynamic effects of cardiac resynchronization therapy in patients with poor left ventricular function during cardiac surgery.
    Hamad MA; van Gelder BM; Bracke FA; van Zundert AA; van Straten AH
    J Card Surg; 2009; 24(5):585-90. PubMed ID: 19740303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
    Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
    Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of left ventricular endocardial activation pattern on echocardiographic and clinical response to cardiac resynchronization therapy.
    Fung JW; Chan JY; Yip GW; Chan HC; Chan WW; Zhang Q; Yu CM
    Heart; 2007 Apr; 93(4):432-7. PubMed ID: 17237127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of LOw-dose DObutamine stress-echocardiography to predict cardiac resynchronization therapy response (LODO-CRT) multicenter prospective study: design and rationale.
    Muto C; Gasparini M; Iacopino S; Peraldo C; Curnis A; Sassone B; Diotallevi P; Davinelli M; Valsecchi S; Tuccillo B
    Am Heart J; 2008 Oct; 156(4):656-61. PubMed ID: 18926147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epicardial left ventricular lead placement for cardiac resynchronization therapy: optimal pace site selection with pressure-volume loops.
    Dekker AL; Phelps B; Dijkman B; van der Nagel T; van der Veen FH; Geskes GG; Maessen JG
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1641-7. PubMed ID: 15173718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiac resynchronization therapy by biventricular pacing. How many patients with left ventricular dysfunction are eligible?].
    Yang A; Wolpert C; Schimpf R; Schulz T; Krause U; Jung W; Herwig S; Jeong KM; Omran H; Lewalter T; Lüderitz B
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2259-63. PubMed ID: 12397540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and chronic effects of cardiac resynchronization in patients developing heart failure with long-term pacemaker therapy for acquired complete atrioventricular block.
    Shimano M; Tsuji Y; Yoshida Y; Inden Y; Tsuboi N; Itoh T; Suzuki H; Muramatsu T; Okada T; Harata S; Yamada T; Hirayama H; Nattel S; Murohara T
    Europace; 2007 Oct; 9(10):869-74. PubMed ID: 17557768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy.
    Ypenburg C; Sieders A; Bleeker GB; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Am Heart J; 2007 Dec; 154(6):1160-5. PubMed ID: 18035090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heart re-synchronization with biventricular stimulation: new treatment for refractory heart failure].
    Daubert JC; Leclercq C; Mabo P
    Bull Acad Natl Med; 2002; 186(1):45-55; discussion 56-7. PubMed ID: 12146141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure.
    Yannopoulos D; Lurie KG; Sakaguchi S; Milstein S; Ermis C; VanHeel L; Benditt DG
    J Am Coll Cardiol; 2007 Sep; 50(13):1246-51. PubMed ID: 17888841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.